�Neuropharma, Zeltia's subsidiary, devoted to the
research and development of innovative drugs for the treatment of
neurodegenerative diseases, reported new results in the International Conference
on Alzheimer's Disease, held in Chicago (USA) on July 26-31, 2008.
Dr. Gomez-Isla, Head of Section of Neurology at the Hospital Santa Cruz y San
Pablo, and scientific consultant of Neuropharma, reported in the symposium "Animal
and cellular models" the efficaciousness results of NP-12 in a
